Condor Software Raises $24 Million Series A Funding to Build the First Financial Intelligence Platform for Life Sciences [Yahoo! Finance]
ACADIA Pharmaceuticals Inc. (ACAD)
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
Company Research
Source: Yahoo! Finance
sciences companies to see, predict, and control the cost of bringing life-changing therapies to patients SAN DIEGO March 18, 2026 /PRNewswire/ -- Condor Software , the Financial Intelligence Platform for life sciences, today announced it has closed a $24 million Series A funding round led by global software investor Insight Partners, with participation from Felicis, 645 Ventures, Pamir Ventures, SNR Ventures, Prebys Ventures, and Bramalea Partners. Condor has raised a total of $36 million in funding. Condor Pharmaceutical companies spend an estimated $300 billion annually on R&D. While AI is rapidly reshaping how drugs are discovered and developed, the financial infrastructure that determines which programs get funded still runs on spreadsheets that require manual reconciliation across disconnected CRO portals, ERP systems, and accounting tools. As a result, many promising trials are paused or cancelled because accounting, FP&A, and clinical operations teams lack real-time clari
Show less
Read more
Impact Snapshot
Event Time:
ACAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACAD alerts
High impacting ACADIA Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ACAD
News
- ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year [Yahoo! Finance]Yahoo! Finance
- Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]Yahoo! Finance
- Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS ForumBusiness Wire
- ACADIA Pharmaceuticals Showcases $1B+ Net Sales, $800M Cash, and Key Alzheimer's Readout Ahead [Yahoo! Finance]Yahoo! Finance
ACAD
Earnings
- 2/25/26 - Beat
ACAD
Sec Filings
- 3/20/26 - Form 4
- 3/20/26 - Form 3
- 3/10/26 - Form 4
- ACAD's page on the SEC website